Funded projects
PROGRAM NO. AGREEMENT | THE DIRECTOR OF THE PROJECT, RESPONSIBLE PARTNER | TITLE | DURATION |
64 PCCDI/2018 | 64 PCCDI/2018 Responsible partner: Mendi CIȘMAȘIU In charge of the project: Gina MANDA | The development of radiopharmaceuticals and techniques in nuclear oncology imaging and treatment is tailored to the molecular level | 2018-2021 |
The COST of the Action AS the 17103 | Project manager VA Gomeza, Spain. Responsible Romania, Gerard Hen | The Delivery of the Antisense RNA Therapeutics | 2018-2023 |
PN 19.29.02.01 | Bogdan Ovidiu Popescu. | The effect of the by-products of intestinal microbiota and proteins in the amyloid plaques of the functional impact of the aggregation of pathological proteins, and the propagation of the pathology of the model prionic in models of neurodegeneration | 2019-2023 |
PN 19.29.01.03 | Laura Cristina-Ceafalan | Technological innovation regarding the detection of genetic fingerprints – applications in the monitoring of residual tumor cells as well as of the hematopoietic regeneration post-transplant | 2019-2022 |
PNRR-III-C9-2022 – 5 – 14 | The responsible work Package Laura Cristina-Ceafalan | Creation, Operational and Development of the National Center of Competence in the field of Cancer (NCCC) | 2022-2025 |
PN 23.16.01.02 | Laura Cristina-Ceafalan | Sarcopenia-associated neurodegenerative diseases: the definition of the molecular basis of cross-linking on the axis of the brain-to-striated muscle in order to identify prognostic factors and therapeutic targets | 2023-2026 |
English (UK) 
Română